Dr William John Geimeier, MD | |
179 W Chestnut Hill Rd, Suite 1, Newark, DE 19713-2210 | |
(302) 453-1343 | |
(302) 453-1654 |
Full Name | Dr William John Geimeier |
---|---|
Gender | Male |
Speciality | Allergy & Immunology - Allergy |
Location | 179 W Chestnut Hill Rd, Newark, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003848474 | NPI | - | NPPES |
397142 | Other | MAMSI | |
0000048901 | Medicaid | DE | |
0078796000 | Other | AMERIHEALTH | |
511251 | Other | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | C1-0001765 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr William John Geimeier, MD 179 W Chestnut Hill Rd, Suite 1, Newark, DE 19713-2210 Ph: (302) 453-1343 | Dr William John Geimeier, MD 179 W Chestnut Hill Rd, Suite 1, Newark, DE 19713-2210 Ph: (302) 453-1343 |
News Archive
Patients receiving anterior cruciate ligament (ACL) knee reconstruction with a hamstring tendon graft rather than a knee tendon graft were less likely to suffer from pain and mobility issues15 years after surgery, say researchers presenting a study today at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Diego, California (February 19).
Year-old babies who do not respond when their name is called may be more likely to be diagnosed with an autism spectrum disorder or other developmental problem at age 2, making this simple test a potential early indicator for such conditions, according to a report in the April issue of Archives of Pediatrics & Adolescent Medicine, a theme issue on autism spectrum disorders.
Ionizing radiation is not without danger to human populations. Indeed, exposure to nuclear radiation leads to an increase in male births relative to female births, according to a new study by Hagen Scherb and Kristina Voigt from the Helmholtz Zentrum München.
Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, a combination of IL2 therapy and activation of patients' immune systems using personalized vaccines made from their own tumor cells has been shown to improve survival rates even more than IL2 alone, according to a new article in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
› Verified 9 days ago
Junfang Jiao, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300 Fax: 302-543-8456 | |
Dr. Quan Chung Nguyen, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300 Fax: 302-543-8456 | |
Sokun Ky Bhatti, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300 | |
Thomas Graves, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300 |